StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$1.92+0.05 (+2.95%)

Close on Nov 16, 2026Market cap $86.87MP/E –Yield –

Genelux EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Genelux

Genelux has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genelux figures

See a number that looks wrong?